Harada M, Yamashita A, Aburada M. J Pharm Soc Japan 92:750-756 (1972). Hirai A, Terano T, Hamazaki T et al. Throm Res. 31:29-40 (1983). Zhang WG, Zhang ZS. Acta Pharm Sinica 29:145-148 (1994).
의 억제제:
HSF3, LITAF, TIMP-3.
의 활성화자:
TCP-1 ζ2.
모습 :
Crystalline
건강 상태 :
Solid
용해도 :
Soluble in water (<1 mg/ml at 25° C), methanol, DMSO (33 mg/ml at 25° C), and ethanol (33 mg/ml at 25° C).
저장 :
Store at room temperature
녹는점 :
48-50° C (lit.)
비등점 :
154° C (lit.) at 20 mmHg
밀도 :
~1.2 g/cm3 (Predicted)
굴절률 :
n20D 1.54 (Predicted)
IC50 :
Sprague-Dawley rat lens alodse reductase : IC50 = >50 µM; Formation of advanced glycation end product : IC50 = >5 mM